Addressing COVID-19 Screening Delays: The Impact of HPV Self-Sampling on Non-Attenders in a Cervical CancerScreening Program

A. Chiereghin et al.

Source

Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen)

Anita W. W. Lim et al.

Source

Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs

Michele Qi et al.

Source

Copan MSwab® maintains HPV nucleic acid stability after long term storage

Stefania Di Costanzo, Simone Paghera, Michele Rosso, Cristiano Sabelli

Copan MSwab® maintains HPV nucleic acid stability at challenging temperatures

Stefania Di Costanzo, Simone Paghera, Michele Rosso, Cristiano Sabelli

Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples

Marianna Martinelli et al.

Source

Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial

Rachel L. Winer et al.

Source

Preliminary Results of Feasibility and Acceptability ofSelf-Collection for Cervical Screening in Italian Women

Illari Sechi et al.

Source

Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer:implementation studies from five sub-Saharan African countries

Jessica Joseph et al.

Source

Age-specific and genotype-specific carcinogenic human papilloma virus prevalence in a country with a high cervical cancer burden: results of across-sectional study in Estonia

Kersti Pärna et al.

Source

Genotype heterogeneity of high-risk human papillomavirus infection in Ethiopia

Ayichew Seyoum  et al.

Source